The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases
Abstract
Aldehyde dehydrogenase (ALDH) 2 is a mitochondrial enzyme that is known for its important role in oxidation and detoxification of ethanol metabolite acetaldehyde. ALDH2 also metabolizes other reactive aldehydes such as 4-hydroxy-2-nonenal and acrolein. The Glu504Lys single nucleotide polymorphism (SNP) of ALDH2 gene, which is found in approximately 40% of the East Asian populations, causes defect in the enzyme activity of ALDH2, leading to alterations in acetaldehyde metabolism and alcohol-induced “flushing” syndrome. Evidence suggests that ALDH2 Glu504Lys SNP is a potential candidate genetic risk factor for a variety of chronic diseases such as cardiovascular disease, cancer, and late-onset Alzheimer’s disease. In addition, the association between ALDH2 Glu504Lys SNP and the development of these chronic diseases appears to be affected by the interaction between the SNP and lifestyle factors such as alcohol consumption as well as by the presence of other genetic variations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ALDH2 deficiency has been linked to increased rates of cancer and CVD”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Zhao and Wang, 2015
In the citing paper
“and it may be a risk factor for Alzheimer disease”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Zhao and Wang, 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
Self-citationTamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Guglielmotto, M., Santoro, G., Davit, A., Danni, O., Smith, M. A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02895.x · Cited by 324
Sydow, K., Daiber, A., Oelze, M., Chen, Z., August, M., Wendt, M., Ullrich, V., Mülsch, A., Schulz, E., Keaney, J. F., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419267 · Cited by 300
Klyosov, A. A., Rashkovetsky, L. G., Tahir, M. K., & Keung, W.-M. (1996) · Biochemistry · doi:10.1021/bi9521093 · Cited by 200 · cited 1×
“The Glu504Lys single nucleotide polymorphism (SNP) of ALDH2 gene, which occurs with an incidence of 35–57% in different East Asian subpopulations, causes defect in the enzyme activity of ALDH2, leading to alterations in acetaldehyde metabolism and markedly reduced alcohol tolerance [3, 4].”
Background
Research works printed but not linked: 82
- 10.1097/01.alc.0000187161.07820.21 · DOI
- 10.1172/jci113875 · DOI · Paper page
- 1983, The American Journal of Human Genetics, 35, 769
- 10.1006/bbrc.2000.2923 · DOI · Paper page
- 10.1089/dna.2013.1995 · DOI
- 10.1016/j.arcmed.2013.10.002 · DOI
- 10.1093/carcin/19.8.1383 · DOI · Paper page
- 2005, Human Genomics, 2, 138, 10.1186/1479-7364-2-2-138 · DOI · Paper page
- 1962, The Journal of Biological Chemistry, 237, 677, 10.1016/S0021-9258(18)60354-0 · doi:10.1016/s0021-9258(18)60354-0
- 10.1006/bbrc.1995.2168 · DOI
- 10.1042/bj3160317 · doi:10.1042/bj3160317
- 10.1042/bj1520201 · doi:10.1042/bj1520201
- 10.1006/taap.1998.8486 · DOI
- 10.1172/jci119176 · DOI · Paper page
- 10.1016/0165-1218(91)90128-9 · DOI · Paper page
- 10.1074/jbc.273.18.10893 · DOI · Paper page
- 10.1007/978-1-4612-2550-8_2 · DOI · Paper page
- 1996, Journal of Investigative Medicine, 44, 42
- 10.3109/15563650.2012.672743 · DOI
- 10.1016/s0969-2126(97)00224-4 · DOI · Paper page
- 1994, The Journal of Biological Chemistry, 269, 13854, 10.1016/S0021-9258(17)36725-X · DOI
- 10.1074/jbc.m502345200 · DOI
- 10.1186/1479-7364-3-2-121 · DOI
- 10.7326/0003-4819-127-5-199709010-00007 · DOI
- 10.1097/01.alc.0000172457.62535.ee · doi:10.1097/01.alc.0000172457.62535.ee
- 10.1111/j.1530-0277.1995.tb01557.x · DOI
- 10.1002/hup.755 · doi:10.1002/hup.755
- 10.1016/j.biopsych.2009.10.005 · DOI
- 10.1007/s10038-003-0046-y · DOI
- 10.1016/j.pharmthera.2011.05.008 · DOI · Paper page
- 10.1016/j.yjmcc.2005.11.006 · DOI
- 10.1161/CIRCULATIONAHA.108.823799 · DOI · Paper page
- 10.1016/S1071-9164(00)90012-5 · DOI
- 10.1179/135100007x200308 · DOI
- 10.1152/ajpheart.00120.2011 · DOI
- 10.1093/cvr/cvu125 · DOI
- 10.1385/ct:4:1:21 · DOI
- 10.1073/pnas.95.2.510 · DOI · Paper page
- 10.1016/j.yjmcc.2008.03.020 · DOI
- 10.1093/eurheartj/ehq253 · DOI · Paper page
- 10.1016/j.atherosclerosis.2010.05.024 · DOI
- 10.1172/jci26564 · DOI · Paper page
- 10.1093/eurheartj/ehs061 · DOI
- 10.1161/circresaha.109.206607 · DOI
- 10.1291/hypres.24.365 · DOI
- 10.1291/hypres.25.857 · DOI
- 10.1291/hypres.30.585 · DOI
- 10.1038/hr.2009.3 · DOI
- 10.1038/jhh.2012.15 · DOI
- 1987, Journal of Pharmacology and Experimental Therapeutics, 240, 59, 10.1016/S0022-3565(25)22707-0 · DOI
- 10.1186/1471-2261-12-58 · DOI
- 10.1097/fpc.0b013e32835b1707 · DOI
- 10.1016/s0891-5849(01)00744-4 · DOI · Paper page
- 10.1111/j.1530-0277.2001.tb02388.x · DOI
- 1988, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 44, 101
- 10.1093/carcin/22.6.913 · DOI · Paper page
- 10.1002/ijc.22199 · DOI
- 10.1002/hep.1840060330 · DOI · Paper page
- 10.1111/j.1349-7006.2012.02360.x · DOI
- 10.1111/j.1530-0277.1999.tb04064.x · DOI
- 10.1002/ijc.22792 · DOI
- 10.1093/carcin/bgt080 · DOI
- 10.1371/journal.pone.0088779 · DOI
- 10.2169/internalmedicine.52.1202 · doi:10.2169/internalmedicine.52.1202
- 10.1371/journal.pone.0088656 · DOI
- 10.1007/s13277-011-0309-8 · DOI
- 10.1097/00008571-200302000-00002 · DOI
- 10.2188/jea.je20081035 · DOI
- 10.1126/science.1132814 · DOI · Paper page
- 10.1056/nejmra0909142 · DOI · Paper page
- 1997, Journal of Neurochemistry, 68, 2092, 10.1046/j.1471-4159.1997.68052092.x · DOI · Paper page
- 10.1006/exnr.1998.6890 · DOI
- 10.1046/j.1471-4159.1999.0722323.x · DOI · Paper page
- 10.1046/j.1471-4159.2000.0751234.x · DOI · Paper page
- 10.1016/j.freeradbiomed.2004.11.005 · DOI
- 10.1046/j.1471-4159.2003.01619.x · DOI
- 2006, Journal of Alzheimer's Disease, 9, 155, 10.3233/JAD-2006-9208 · DOI
- 1997, The American Journal of Pathology, 150, 437
- 10.1046/j.1471-4159.2000.0741426.x · DOI
- 10.1016/j.jns.2007.12.006 · DOI
- 10.1016/j.neulet.2009.11.022 · DOI
- 10.1017/S0317167100011938 · DOI
Cited by
Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., et al. (2023) · iScience · doi:10.1016/j.isci.2022.105798 · Cited by 110
Metadata
- Authors
- Zhao, Y., & Wang, C.
- Affiliations
- Department of Bioengineering, Harbin Institute of Technology at Weihai, Shandong 264209, China
- Department of Mathematics, Harbin Institute of Technology at Weihai, Shandong 264209, China
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-9
- ISSN
- 2314-6133
- 2314-6141
- Cited by
- 35
- References
- 4
- Language
- en
- Funders
- National Natural Science Foundation of China (31371082, HIT(WH)Y200902, HIT(WH)Y200903, 2011DXGJ14)
- Harbin Institute of Technology (31371082, HIT(WH)Y200902, HIT(WH)Y200903, 2011DXGJ14)
- Weihai Science and Technology Development Program (31371082, HIT(WH)Y200902, HIT(WH)Y200903, 2011DXGJ14)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases. https://app.cochat.ai/papers/10.1155/2015/174050
- The paper
- Zhao, Y., & Wang, C. (2015). Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases. BioMed Research International. https://doi.org/10.1155/2015/174050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.